"How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor".

Albayrak, Haluk Cihad; Gürler, Fatih; Sütçüoglu, Osman; Akyürek, Nalan; Özet, Ahmet

Albayrak, Haluk Cihad; Gürler, Fatih; Sütçüoglu, Osman; Akyürek, Nalan; Özet, Ahmet.

Affiliation

Albayrak HC; Department of Internal Medicine.
Gürler F; Department of Medical Oncology.
Sütçüoglu O; Department of Medical Oncology.
Akyürek N; Department of Pathology, Gazi University, Ankara, Turkey.
Özet A; Department of Medical Oncology.

Anticancer Drugs ; 33(1): 109-111, 2022 01 01.

Article in En | MEDLINE | ID: mdl-34261914

Subject(s)

Antineoplastic Agents/therapeutic use; Crizotinib/therapeutic use; Lung Neoplasms/drug therapy; Neoplasms, Muscle Tissue/drug therapy; Anaplastic Lymphoma Kinase/genetics; Female; Humans; Lung Neoplasms/genetics; Middle Aged; Neoplasms, Muscle Tissue/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crizotinib / Lung Neoplasms / Neoplasms, Muscle Tissue / Antineoplastic Agents Limits: Female / Humans / Middle aged Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google